Skip to content

Multicenter, Self-Controlled Clinical Trial Evaluating the Effectiveness and Performance of HyVision Ablation Planning for Puncture Path Planning in Thoracoabdominal Organs

Multicenter, Self-Controlled Clinical Trial Evaluating the Effectiveness and Performance of HyVision Ablation Planning for Puncture Path Planning in Thoracoabdominal Organs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100531
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic and pulmonary space-occupying lesions

Interventions

The liver/pulmonary observation group:None

Sponsors

Beijing Youan Hospital Capital Medical University/Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 18 years or older (based on the date of imaging examination), regardless of gender; 2.Possessing images from contrast-enhanced CT scans of the thorax and/or abdomen; 3.Undergoing CT-guided percutaneous biopsy due to focal hepatic or pulmonary lesions.

Exclusion criteria

Exclusion criteria: 1.The images do not meet the following format requirements: contrast-enhanced CT images in DICOM 3.0 standard format with a slice thickness of =16 rows, tube voltage of >=100 kVp, tube current of >=80 mAs, and resolution of >=512×512 pixels; 2.The images exhibit various low-quality conditions that affect image interpretation and planning (e.g., artifacts, insufficient resolution); 3.A rational biopsy trajectory cannot avoid critical organs and osseous structures such as ribs and scapulae, nor can it avoid structures such as bullae, large vessels, trachea, interlobar fissures, and bile ducts; 4.The investigator deems the case unsuitable for inclusion in this clinical trial.

Design outcomes

Primary

MeasureTime frame
The success rate of the planning protocol.;Planning protocol duration;

Secondary

MeasureTime frame
Evaluation of Organ Segmentation Accuracy;Evaluation of Device Performance;

Countries

China

Contacts

Public ContactYonghong Zhang / Xiaoguang LI

Beijing Youan Hospital Capital Medical University / Beijing Hospital

zhangyh@ccmu.edu.cn+86 10 8399 7644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026